US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

234.04

+11.044.95%

Volume:112.52K

Turnover:25.79M

Market Cap:614.24M

PE:- -

High:234.27

Open:223.71

Low:222.88

Close:223.00

52wk High:341.93

52wk Low:102.35

Shares:2.62M

Float Shares:2.62M

Volume Ratio:2.93

T/O Rate:4.29%

Dividend:0.91

Dividend Rate:0.39%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Fisher & Paykel Healthcare Sells Drury Land to Health NZ for Future Hospital

Vital Healthcare Sets 2026 AGM to Ratify Manager and Board Reappointments

Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX) and Integra Lifesciences (IART)

Wall Street Analysts Are Bullish on Top Healthcare Picks

The Oceania Healthcare Dispute Was About Profit, Not Growth

Simply Wall St.

Aveanna Healthcare director resignation prompts governance reshuffle

Healthcare Stocks Fall Slightly

Teknova and Pluristyx Announce FDA Drug Master File for the PluriFreeze™ Cryopreservation System

FDA ends outbreak investigation of Cyclospora infections linked to lettuce

Analysts Offer Insights on Healthcare Companies: Nexalin Technology, Inc. (NXL) and Gain Therapeutics (GANX)

Analysts Offer Insights on Healthcare Companies: Autolus Therapeutics (AUTL) and Rocket Pharmaceuticals (RCKT)

Sector Update: Healthcare

MT Newswires Live

Exchange-Traded Funds Rise as US Equities Advance After Midday

MT Newswires Live

Legend Biotech Faces Pressure From Rivals Ahead of Key FDA Decision, UBS Says

MT Newswires Live

What Ryman Healthcare's 39% Fall Still Teaches You About Turnarounds

Simply Wall St.

Alliance Healthcare Turns Investment Phase Into Profit as Managed Care Scales Up

Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST) and Legend Biotech (LEGN)

FDA sends letter to Evolus over ‘misleading’ Jeuveau ad

Evolus falls 5% to $7.12 after FDA send letter over marketing

Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE) and Cullinan Management (CGEM)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/LABU/news?page=11"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":234.04,"timestamp":1791554067580,"preClose":223,"halted":0,"volume":112519,"delay":0,"changeRate":0.04950672645739907,"floatShares":2624500,"shares":2624500,"eps":0,"marketStatus":"Trading","change":11.04,"latestTime":"10-09 09:54:28 EDT","open":223.71,"high":234.27,"low":222.88,"amount":25788434.39458,"amplitude":0.051076,"askPrice":234.62,"askSize":10,"bidPrice":233.66,"bidSize":110,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791576000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":223,"sharesOutstanding":3074486,"nav":227.52,"aum":597123938.28,"dividendRate":0.003907,"bidAskSpread":0.003146,"preHourTrading":{"tag":"盘前","latestPrice":223.28,"preClose":223,"latestTime":"09:28 EDT","volume":2212,"amount":498293.87776,"timestamp":1791552512789,"change":0.28,"changeRate":0.001256,"amplitude":0.01487},"postHourTrading":{"tag":"盘后","latestPrice":223.66,"preClose":223,"latestTime":"19:57 EDT","volume":4124,"amount":918785.7173,"timestamp":1791503872443,"change":0.66,"changeRate":0.00296,"amplitude":0.008427},"volumeRatio":2.927981,"impliedVol":1.0498,"impliedVolPercentile":0.9203},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2624500,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.927981,"shares":2624500,"dividePrice":0.9143,"high":234.27,"amplitude":0.051076,"preClose":223,"low":222.88,"week52Low":102.3547,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":234.04,"committee":0.833333,"eps":0,"divideRate":0.003907,"volume":112519,"delay":0,"ttmEps":0,"open":223.71,"prevYearClose":159.39,"prevWeekClose":248.72,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":248.72,"twentyDayClose":261.3,"sixtyDayClose":254.8},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:11,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673775183","title":"Fisher & Paykel Healthcare Sells Drury Land to Health NZ for Future Hospital","url":"https://stock-news.laohu8.com/highlight/detail?id=2673775183","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673775183?lang=en_us&edition=fundamental","pubTime":"2026-10-05 03:47","pubTimestamp":1791143261,"startTime":"0","endTime":"0","summary":"Fisher & Paykel Healthcare Corporation Limited ( ($NZ:FPH) ) has shared an announcement. Fisher & Paykel Healthcare has agreed to sell 13 hectares ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fisher-paykel-healthcare-sells-drury-land-to-health-nz-for-future-hospital?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fisher-paykel-healthcare-sells-drury-land-to-health-nz-for-future-hospital?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4581","BK4585","XBI","XLV","FPH.NZ","BK8004","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673185775","title":"Vital Healthcare Sets 2026 AGM to Ratify Manager and Board Reappointments","url":"https://stock-news.laohu8.com/highlight/detail?id=2673185775","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673185775?lang=en_us&edition=fundamental","pubTime":"2026-10-05 03:47","pubTimestamp":1791143250,"startTime":"0","endTime":"0","summary":"Vital Healthcare Property ( ($NZ:VHP) ) has provided an update. Vital Healthcare Property Trust has issued its 2026 Annual Meeting notice, virtual ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vital-healthcare-sets-2026-agm-to-ratify-manager-and-board-reappointments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vital-healthcare-sets-2026-agm-to-ratify-manager-and-board-reappointments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","XLV","HCSG","BK4137","BK8059","BK4585","BK4588","XBI","BK4581","LABU","LU0128526141.USD","BK8073","VHP.NZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672725428","title":"Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX) and Integra Lifesciences (IART)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672725428","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672725428?lang=en_us&edition=fundamental","pubTime":"2026-10-03 21:40","pubTimestamp":1791034821,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Perspective Therapeutics (CATX) and Integra Lifesciences (IART). ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-perspective-therapeutics-catx-and-integra-lifesciences-iart-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-perspective-therapeutics-catx-and-integra-lifesciences-iart-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","XLV","LU0029874061.USD","BK4139","IART","LU0128526141.USD","BK4588","HCSG","BK4581","CATX","BK4585","BK4137","BK4082","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672742406","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2672742406","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672742406?lang=en_us&edition=fundamental","pubTime":"2026-10-03 09:50","pubTimestamp":1790992231,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Insulet (PODD) and Viridian Therapeutics (VRDN) with...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-369?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-369?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","LU0728928796.USD","BK4082","LABU","BK4566","VRDN","XLV","XBI","PODD","BK4137","BK4585","BK4139","LU2324357040.USD","LU0029874061.USD","BK4551","BK4588","LU2065171402.SGD","LU1084165304.USD","LU2065171311.SGD","LU2065170008.USD","BK4581","LU2065169927.USD","LU0128526141.USD","LU1119994496.HKD","LU1261432733.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672747267","title":"The Oceania Healthcare Dispute Was About Profit, Not Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2672747267","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672747267?lang=en_us&edition=fundamental","pubTime":"2026-10-03 08:34","pubTimestamp":1790987677,"startTime":"0","endTime":"0","summary":"If you had backed Oceania Healthcare on 1 January and simply held through recent results, the outcome would sting. Holding Oceania Healthcare from the start of the year would have meant a 21.5% loss, including dividends. That decline now sits alongside a period where revenue reached NZ$135.769 million in H2 2026 while net income swung to a loss. If those were the final numbers, what did the original 13.8% revenue growth and 29.3% margin assumptions fail to allow for?\nNarratives are how...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6033000-choice1-card/1788938511465","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6033000-choice1-card/1788938511465"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/nz/healthcare/nzx-oca/oceania-healthcare-shares/news/the-oceania-healthcare-dispute-was-about-profit-not-growth","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/nz/healthcare/nzx-oca/oceania-healthcare-shares/news/the-oceania-healthcare-dispute-was-about-profit-not-growth","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK8050","OCA.NZ","XLV","BK4588","LABU","BK4581","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672415587","title":"Aveanna Healthcare director resignation prompts governance reshuffle","url":"https://stock-news.laohu8.com/highlight/detail?id=2672415587","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672415587?lang=en_us&edition=fundamental","pubTime":"2026-10-03 05:18","pubTimestamp":1790975895,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Aveanna Healthcare Holdings ( ($AVAH) ). On October 1, 2026, Aveanna Healthcare Holdings Inc. announced that Cl...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aveanna-healthcare-director-resignation-prompts-governance-reshuffle?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aveanna-healthcare-director-resignation-prompts-governance-reshuffle?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","XBI","BK4137","BK4585","BK4196","BK4581","BK4588","AVAH","HCSG","LU0029874061.USD","LU0128526141.USD","LABU","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672749751","title":"Healthcare Stocks Fall Slightly","url":"https://stock-news.laohu8.com/highlight/detail?id=2672749751","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672749751?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:51","pubTimestamp":1790974260,"startTime":"0","endTime":"0","summary":"Health-care companies edged lower, as a risk-on mood weighed on the typically defensive sector.Novartis struck a deal valued at up to $7.8 billion to license a messenger RNA drug candidate from Abogen Biosciences and gain options over future therapies, turning to China to fill its pipeline.Many of the world's biggest drugmakers have set their sights on China to look for new drug ideas, seeking to bolster their portfolios in preparation for older medicines going off patent. Novartis has sealed several tie-ups with emerging Chinese biotech players in recent years.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4137","HCSG","BK4585","LU0128526141.USD","XBI","LABU","XLV","LU0029874061.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672674992","title":"Teknova and Pluristyx Announce FDA Drug Master File for the PluriFreeze™ Cryopreservation System","url":"https://stock-news.laohu8.com/highlight/detail?id=2672674992","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672674992?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:01","pubTimestamp":1790971260,"startTime":"0","endTime":"0","summary":"Developers of advanced therapies using PluriFreeze during preclinical stages can seamlessly scale to clinical manufacturing and cross-reference the Drug Master File in FDA submissionsHOLLISTER, Calif.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/02/3374011/0/en/teknova-and-pluristyx-announce-fda-drug-master-file-for-the-plurifreeze-cryopreservation-system.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443978.SGD","LU2746668461.USD","IE00BKVL7J92.USD","LU0170899867.USD","BK4006","LU0149725797.USD","LU0267386448.USD","LU0882574139.USD","CMC","IE00BZ1G4Q59.USD","LU1363072403.SGD","EES","LU2237443895.HKD","IE00B1BXHZ80.USD","DMF","LU2237443382.USD","LU2237443465.HKD","LU2237443622.USD","LU0971096721.USD","IE00BHPRN162.USD","LABU","LU0234572021.USD","BK4585","LU2746668974.SGD","LU2237443549.SGD","IND","IE00BFXG1179.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672874619","title":"FDA ends outbreak investigation of Cyclospora infections linked to lettuce","url":"https://stock-news.laohu8.com/highlight/detail?id=2672874619","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672874619?lang=en_us&edition=fundamental","pubTime":"2026-10-03 03:10","pubTimestamp":1790968223,"startTime":"0","endTime":"0","summary":"The FDA has concluded its outbreak investigation of Cyclospora infections linked to iceberg lettuce sourced from central Mexico and recalled by Tay...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-ends-outbreak-investigation-of-cyclospora-infections-linked-to-lettuce-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-ends-outbreak-investigation-of-cyclospora-infections-linked-to-lettuce-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672746829","title":"Analysts Offer Insights on Healthcare Companies: Nexalin Technology, Inc. (NXL) and Gain Therapeutics (GANX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672746829","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672746829?lang=en_us&edition=fundamental","pubTime":"2026-10-03 02:30","pubTimestamp":1790965805,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Nexalin Technology, Inc. (NXL) and Gain Therapeutics...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-nexalin-technology-inc-nxl-and-gain-therapeutics-ganx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-nexalin-technology-inc-nxl-and-gain-therapeutics-ganx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","HCSG","BK4588","BK4139","BK4082","GANX","BK4137","LABU","BK4581","LU0029874061.USD","LU0128526141.USD","XLV","XBI","NXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672254745","title":"Analysts Offer Insights on Healthcare Companies: Autolus Therapeutics (AUTL) and Rocket Pharmaceuticals (RCKT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672254745","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672254745?lang=en_us&edition=fundamental","pubTime":"2026-10-03 02:00","pubTimestamp":1790964026,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Autolus Therapeutics (AUTL) and Rocket Pharmaceutica...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-autolus-therapeutics-autl-and-rocket-pharmaceuticals-rckt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-autolus-therapeutics-autl-and-rocket-pharmaceuticals-rckt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","XLV","HCSG","BK4581","XBI","LABU","AUTL","BK4137","BK4139","BK4588","RCKT","LU0029874061.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672745865","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2672745865","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672745865?lang=en_us&edition=fundamental","pubTime":"2026-10-03 01:14","pubTimestamp":1790961293,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined Friday afternoon, with the NYSE Healthcare Index easing 0.1% and the State Street Health Care Select Sector SPDR ETF  decreasing 0.3%.The iShares Biotechnology ETF  was shedding 0.7%.In corporate news, AstraZeneca  and Japan's Daiichi Sankyo have partnered with Summit Therapeutics  to test their drug Datroway plus ivonescimab to treat lung, breast, and other cancers, the companies said Friday. AstraZeneca shares were down 0.7%, and Summit rose 0.7%.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0310800379.SGD","LU2468319806.SGD","LU2237443549.SGD","LU2488822045.USD","LU2089984988.USD","LU0029864427.USD","LU2417539215.USD","BK4007","LU0128526141.USD","LU2237443622.USD","BK4568","BK4585","LU0029874061.USD","LU2237443382.USD","HCSG","LU2462157665.USD","BK4139","XBI","SMMT","LU0128525929.USD","BK4137","LU0289739699.SGD","LU0889565916.HKD","LU1267930573.SGD","LU1829250122.USD","XLV","IE00B3T34201.USD","LU2456880835.USD","IBB","LU0058720904.USD","LU2236285917.USD","BK4588","LU0432979614.USD","LABU","LU2237443895.HKD","BK4581","LU0708994859.HKD","LU2237443465.HKD","AZNH","AZN","LU0320765992.SGD","LU2237443978.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672745888","title":"Exchange-Traded Funds Rise as US Equities Advance After Midday","url":"https://stock-news.laohu8.com/highlight/detail?id=2672745888","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672745888?lang=en_us&edition=fundamental","pubTime":"2026-10-03 01:13","pubTimestamp":1790961204,"startTime":"0","endTime":"0","summary":"Broad Market IndicatorsBroad-market exchange-traded funds IWM and IVV were higher. Actively traded Invesco QQQ Trust (QQQ) added 1%.US equity indexes rose after a weak September jobs report slashed th","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ETH.USD.CC","QID","SBIT","NAPR","CBOA","DGZ","SIVR","BITB","GSE","XLY","BK4581","VDC","XAUUSD.FOREX","ZSL","BITI","BTRN","XBI","EETH","SHNY","BRRR","BK4534","AAAU","ARKB","BK4570","TECL","KGLD","BPI","BITO","BTF","GPIQ","QDEC","CBOJ","SOXL","BETE","BAR","EZBC","IAU","RTH","XLPU","GLDY","UGL","OUNZ","CBXO","CBOY","QQQ","RETL","ESK","UCO","FGDL","XLE","XLV","BK4504","BK4593","QQQX","CBOO","BK4547","BTCW","ETQ","USG","LABU","BAGY","DGP","ETCO","SQQQ","USO","TQQY","XLF","BTC.USD.CC","XLP","BTCL","BTC","ETH","XSD","SCO","CBXY","BTCO","IYH","FBTC","DFII","BTCI","IYE","IYJ","BITX","IYW","BK4585","TETH","NDX","YGLD","BK4550","QLD","NJAN","BTCC","XAGUSD.FOREX","CBTY","MNRS","BITU","QQQM","FAZ","NJUL","XLPD","VHT","GLD","AGQ","FAS","SGOL","XLI","NOCT","IBB","IGM","QBF","YBTC","BFJL","IGLD","BETH","CBTA","MAXI","GLL","XRT","DEFI","BGLD","BITY","IAUI","BCCC","BK4588","ETHD","IBIT","SOXX","SLV","CBXA","GLDM","QMAR","VIS","BFAP","GBTC","SETH","CBXJ","BK4561","CBTJ","XLK","XBTY","PSQ","DZZ","UNG","CBTO","HODL","SOXS","IAUM","DULL","TQQQ","ETHT","BTCZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672034743","title":"Legend Biotech Faces Pressure From Rivals Ahead of Key FDA Decision, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2672034743","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672034743?lang=en_us&edition=fundamental","pubTime":"2026-10-03 01:05","pubTimestamp":1790960723,"startTime":"0","endTime":"0","summary":"Legend Biotech's (LEGN) multiple myeloma therapy Carvykti is facing growing competitive pressure as Gilead Sciences' (GILD) anito-cel approaches a potential approval and Johnson & Johnson's (JNJ) Tec-","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TBXU","VHT","TMED","LU0545562505.USD","IE0034235303.USD","IE00BKVL7J92.USD","LU1057294990.SGD","GDOC","FTXH","MEDX","JNJ","LU0426417589.USD","IE00BLSP4239.USD","BK4550","CANC","GILD","LEGN","LU0345769631.USD","LU0545039389.USD","IBBQ","LU0345770308.USD","LU0889566641.SGD","FHLC","IE00BLSP4452.SGD","SG9999001440.SGD","LU2129689605.HKD","LU0320765992.SGD","BMED","BIB","IHE","IXJ","PJP","MEMS","XLV","XBI","LU1261432733.SGD","IE00B42XCP33.USD","LU1162221912.USD","TRUH","JDOC","IYH","LABU","LU1585245621.USD","MEDI","BBH","LU1221951046.USD","RXL","IBB","BK4504","LU0859254822.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672746754","title":"What Ryman Healthcare's 39% Fall Still Teaches You About Turnarounds","url":"https://stock-news.laohu8.com/highlight/detail?id=2672746754","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672746754?lang=en_us&edition=fundamental","pubTime":"2026-10-03 00:24","pubTimestamp":1790958261,"startTime":"0","endTime":"0","summary":"If you had decided on 1 January 2026 that Ryman Healthcare looked too messy to touch, the next nine months would have tested that call. Investors who held Ryman Healthcare from the start of the year are down 39.0%, including dividends. That drop sits alongside headlines about bond raises, governance tweaks, cash flow shifts, and still-deep losses. What assumption about its debt-heavy, development-driven model could you have interrogated back then to judge that risk?\nIf the move has made Ryman...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6033000-choice1-card/1788938511465","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6033000-choice1-card/1788938511465"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/nz/healthcare/nzx-rym/ryman-healthcare-shares/news/what-ryman-healthcares-39-fall-still-teaches-you-about-turna","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/nz/healthcare/nzx-rym/ryman-healthcare-shares/news/what-ryman-healthcares-39-fall-still-teaches-you-about-turna","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XLV","BK4588","BK4585","XBI","LABU","BK8050","BK4581","RYM.NZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672748507","title":"Alliance Healthcare Turns Investment Phase Into Profit as Managed Care Scales Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2672748507","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672748507?lang=en_us&edition=fundamental","pubTime":"2026-10-02 23:16","pubTimestamp":1790954167,"startTime":"0","endTime":"0","summary":"Alliance Healthcare Group Ltd. ( ($SG:MIJ) ) has shared an announcement. Alliance Healthcare Group has marked FY2026 as an inflection year, convert...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alliance-healthcare-turns-investment-phase-into-profit-as-managed-care-scales-up?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alliance-healthcare-turns-investment-phase-into-profit-as-managed-care-scales-up?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4137","HCSG","BK4585","SG","LU0128526141.USD","BK4209","XBI","LABU","XLV","LU0029874061.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672710153","title":"Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST) and Legend Biotech (LEGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672710153","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672710153?lang=en_us&edition=fundamental","pubTime":"2026-10-02 22:20","pubTimestamp":1790950828,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Envista Holdings (NVST) and Legend Biotech (LEGN). Envista Holdin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-envista-holdings-nvst-and-legend-biotech-legn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-envista-holdings-nvst-and-legend-biotech-legn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1201861165.SGD","BK4585","LU0477156797.USD","LABU","BK4588","LU0128526141.USD","BK4139","HCSG","LU0029874061.USD","BK4581","MEDI","LU0130518102.USD","IE00B19Z6F94.USD","MEMS","NVST","XLV","XBI","BK4137","LU0648000940.SGD","LU0130103400.USD","LEGN","BK4505","CANC","IE0034390439.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672071015","title":"FDA sends letter to Evolus over ‘misleading’ Jeuveau ad","url":"https://stock-news.laohu8.com/highlight/detail?id=2672071015","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672071015?lang=en_us&edition=fundamental","pubTime":"2026-10-02 22:20","pubTimestamp":1790950815,"startTime":"0","endTime":"0","summary":"The FDA posted a letter sent to Evolus (EOLS) regarding the company’s promotional communication for Jeuveau. The FDA determined an Instagram post i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-sends-letter-to-evolus-over-misleading-jeuveau-ad-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-sends-letter-to-evolus-over-misleading-jeuveau-ad-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z8W00.USD","TRUC","LABU","RSPC","FBYY","LU1720051017.SGD","METD","LU1242518931.SGD","LU2720916845.USD","LU2106854487.HKD","XLC","LU1699723380.USD","FBX","METU","FCOM","LU0985489474.SGD","LU1564329461.SGD","FBL","HK0000914686.HKD","SG9999002232.USD","METQ","LTL","VOX","META","METG","METW","SG9999014906.USD","IE00BK4W5L77.USD","XDAT","LU0979878070.USD","NULC","LU0109391861.USD","SMETAmain","LU1232071149.USD","GXPC","EOLS","LU1720051108.HKD","GAMR","LU1074936037.SGD","LU0823434740.USD","IE0009G5SDU7.USD","OGIG","LU1697837992.HKD","IE00B4YYXB79.USD","SOCL","SG9999015952.SGD","LU0211328371.USD","IE00B775H168.HKD","FBY","METV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672101327","title":"Evolus falls 5% to $7.12 after FDA send letter over marketing","url":"https://stock-news.laohu8.com/highlight/detail?id=2672101327","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672101327?lang=en_us&edition=fundamental","pubTime":"2026-10-02 22:20","pubTimestamp":1790950810,"startTime":"0","endTime":"0","summary":"10:19 EDT Evolus (EOLS) falls 5% to $7.12 after FDA send letter over marketing Published first on TheFly – the ultimate source for real-time, marke...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/evolus-falls-5-to-7-12-after-fda-send-letter-over-marketing-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/evolus-falls-5-to-7-12-after-fda-send-letter-over-marketing-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","EOLS","BK4007","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672103667","title":"Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE) and Cullinan Management (CGEM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672103667","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672103667?lang=en_us&edition=fundamental","pubTime":"2026-10-02 22:00","pubTimestamp":1790949616,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Monte Rosa Therapeutics (GLUE) and Cullinan Manageme...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-monte-rosa-therapeutics-glue-and-cullinan-management-cgem-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-monte-rosa-therapeutics-glue-and-cullinan-management-cgem-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4137","HCSG","BK4585","LU0128526141.USD","BK4139","XBI","CGEM","LABU","XLV","BK4539","GLUE","LU0029874061.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":22,"pageCount":11,"totalSize":425,"code":"91000000","status":"200"}]}}